RegenX Science
RegenX Science is dedicated to pioneering breakthroughs in regenerative medicine by developing proprietary biomaterials inspired by nature's healing organisms. The company focuses on accelerating tissue regeneration, optimizing cellular repair, and creating innovative solutions for wound healing and tissue regeneration. Their research-driven approach emphasizes scientific excellence, safety, efficacy, and transparency to transform patient care and improve outcomes.
Industries
Nr. of Employees
small (1-50)
RegenX Science
West Palm Beach, Florida, United States, North America
Products
Extracellular matrix-derived regenerative biomaterial
An ECM-based therapeutic material inspired by regenerative organisms that provides a bioactive scaffold to support cell adhesion, proliferation, and differentiation for wound and tissue repair.
Extracellular matrix-derived regenerative biomaterial
An ECM-based therapeutic material inspired by regenerative organisms that provides a bioactive scaffold to support cell adhesion, proliferation, and differentiation for wound and tissue repair.
Services
Design and execution of safety, toxicology, and biocompatibility studies for regenerative biomaterials using relevant animal models.
Conducting proteomic discovery studies and in vitro genomic analyses to characterize biomaterial composition and biological effects.
Formulation of ECM-derived biomaterials designed to create bioactive microenvironments that promote tissue regeneration.
Advancing products through clinical trials, including trial design and coordination to evaluate safety and efficacy in patients.
Design and execution of safety, toxicology, and biocompatibility studies for regenerative biomaterials using relevant animal models.
Conducting proteomic discovery studies and in vitro genomic analyses to characterize biomaterial composition and biological effects.
Formulation of ECM-derived biomaterials designed to create bioactive microenvironments that promote tissue regeneration.
Advancing products through clinical trials, including trial design and coordination to evaluate safety and efficacy in patients.
Expertise Areas
- Regenerative medicine
- Extracellular matrix biomaterials
- Wound healing and burn recovery
- Preclinical study design and execution
Key Technologies
- Extracellular matrix-based biomaterials
- Proteomics
- In vitro genomics (gene expression profiling)
- Preclinical animal wound-healing models (porcine)
News & Updates
ElevateBio announced a $170 million Series B funding round to develop cellular and genetic therapies, with a focus on creating new companies under its portfolio for specific therapeutic approaches.
Funding to expand research activities at RegenX Science.
Development of hydrogels that support stem cell growth for tissue repair.
Discussion on the potential of stem cells as a groundbreaking medical innovation.
An overview of the regulation of stem cell therapies in clinical settings.
Advances in 3D bioprinting for cardiovascular tissue engineering and potential applications.
ElevateBio announced a $170 million Series B funding round to develop cellular and genetic therapies, with a focus on creating new companies under its portfolio for specific therapeutic approaches.
Funding to expand research activities at RegenX Science.
Development of hydrogels that support stem cell growth for tissue repair.
Discussion on the potential of stem cells as a groundbreaking medical innovation.
An overview of the regulation of stem cell therapies in clinical settings.
Advances in 3D bioprinting for cardiovascular tissue engineering and potential applications.